The success of Viagra initially fueled a surge for major pharmaceutical companies, but recent shifts present a complicated picture for shareholders. Generic versions are reducing earnings, and ongoing patent challenges https://jonasqjud923510.blog2freedom.com/41285077/sildenafil-and-big-pharma-a-risky-play